![Dani Paul Bolognesi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dani Paul Bolognesi
Chief Executive Officer at
B3 Bio, Inc.
Profile
Dani Paul Bolognesi is the founder of B3 Bio, Inc., founded in 2007, serving as Chairman & Chief Executive Officer.
Current jobs include Chief Executive Officer at Enci Therapeutics, Inc., and Director at Senex Biotechnology, Inc. and Istari Oncology, Inc. Former jobs include Director at Transgeneron Therapeutics, Inc., Director at Duke University, Director at InnAVasc Medical, Inc., and Chief Executive & Scientific Officer at Trimeris, Inc. from 1993 to 2004.
Education includes a doctorate from Duke University.
Dani Paul Bolognesi active positions
| Companies | Position | Start |
|---|---|---|
B3 Bio, Inc.
 B3 Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops ribonucleic acid oligonucleotide based drugs | Chief Executive Officer | 2009-09-09 |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Director/Board Member | 2015-12-31 |
Senex Biotechnology, Inc.
 Senex Biotechnology, Inc. BiotechnologyHealth Technology Develops oncology drugs | Director/Board Member | - |
Former positions of Dani Paul Bolognesi
| Companies | Position | End |
|---|---|---|
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | President | - |
InnAVasc Medical, Inc.
 InnAVasc Medical, Inc. Medical SpecialtiesHealth Technology Operates as medical devices company that designs and develops products for vascular access for hemodialysis | Director/Board Member | - |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | - |
Transgeneron Therapeutics, Inc.
 Transgeneron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic medicine that promotes tissue regeneration | Director/Board Member | - |
Training of Dani Paul Bolognesi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
28
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Health Technology |
Transgeneron Therapeutics, Inc.
Transgeneron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic medicine that promotes tissue regeneration | Health Technology |
Senex Biotechnology, Inc.
Senex Biotechnology, Inc. BiotechnologyHealth Technology Develops oncology drugs | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
B3 Bio, Inc.
B3 Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops ribonucleic acid oligonucleotide based drugs | Commercial Services |
InnAVasc Medical, Inc.
InnAVasc Medical, Inc. Medical SpecialtiesHealth Technology Operates as medical devices company that designs and develops products for vascular access for hemodialysis | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Health Technology |
- Stock Market
- Insiders
- Dani Paul Bolognesi
